-
Mashup Score: 137th Annual Hereditary Cancer Symposium for Health Care Providers - Virtual Environment - MDA - Continuing Education (CE) - 11 month(s) ago
MDA, 7th Annual Hereditary Cancer Symposium for Health Care Providers – Virtual Environment, 4/5/2024 7:00:00 AM – 4/6/2024 12:00:00 PM, This Symposium is targeted to inter-professional healthcare providers working with Clinical Cancer Genetics. The event will give attendees the awareness of cancer treatment options and appropriate referrals tailored to genetic testing results.
Source: mdanderson.cloud-cme.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 36th Interdisciplinary Pain and Opioid Crisis Seminar - MDA - Continuing Education (CE) - 11 month(s) ago
MDA, 6th Interdisciplinary Pain and Opioid Crisis Seminar, 4/19/2024 7:30:00 AM – 4/20/2024 2:00:00 PM, The 6th Pain and Opioid Crisis Seminar provides a unique opportunity for healthcare providers to achieve this much needed balance by enhancing their knowledge and competencies in the use of opioids. It will offer cutting-edge lectures and interactive panel discussions from worldwide expert faculty with diverse clinical and research backgrounds in pain and opioids. This exciting educational event will provide practical evidence-based guidance and solutions to address clinical, public health, and regulatory issues related to the use and nonmedical use of opioids. Attendees will obtain up-to-date information and acquire high-quality knowledge while earning valuable CE credits and NCPD contact hours as well as Maintenance of Certification (MOC) points from the American Board of Internal Medicine (ABIM) and American Board of Anesthesiology (ABA).
Source: mdanderson.cloud-cme.comCategories: General Medicine News, Onc News and JournalsTweet-
Health care providers are invited to join MD Anderson’s Interdisciplinary Pain and Opioid Crisis Virtual Seminar on April 19-20. Register today: https://t.co/r0C6L994xO. #EndCancer
-
-
Mashup Score: 1Cancer Neuroscience Symposium - MDA - Continuing Education (CE) - 11 month(s) ago
MDA, Cancer Neuroscience Symposium, 2/28/2024 1:00:00 PM – 3/1/2024 4:00:00 PM, MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes. This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring
Source: mdanderson.cloud-cme.comCategories: General Medicine News, Onc News and JournalsTweet-
🌟The 2024 Cancer Neuroscience Symposium is not just an event; it's an experience. More than 30 experts will share their insights, shaping the future of cancer research. Take part in this transformative journey—register NOW! @MDAndersonNews #EndCancer https://t.co/N7biXYS46E https://t.co/WewUGFwjGf
-
-
Mashup Score: 1Cancer Neuroscience Symposium - MDA - Continuing Education (CE) - 11 month(s) ago
MDA, Cancer Neuroscience Symposium, 2/28/2024 1:00:00 PM – 3/1/2024 4:00:00 PM, MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes. This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring
Source: mdanderson.cloud-cme.comCategories: General Medicine News, General HCPsTweet-
🌟 The 2024 Cancer Neuroscience Symposium is not just an event; it's an experience. More than 30 experts will share their insights, shaping the future of cancer research. Take part in this transformative journey—register NOW! @MDAndersonNews #EndCancer https://t.co/CgbI5XZEJB https://t.co/efiCp8hdv5
-
-
Mashup Score: 31st International Conference on Polyploid Giant Cancer Cells: Biology and Clinical Applications - MDA - Continuing Education (CE) - 11 month(s) ago
MDA, 1st International Conference on Polyploid Giant Cancer Cells: Biology and Clinical Applications, 2/16/2024 7:00:00 AM – 2/17/2024 5:00:00 PM, We cordially invite Scientists, Oncologists, Post-Doctoral Fellows, and Graduate Students engaged in cancer research to join us for the inaugural International Conference on Polyploid Giant Cancer Cells. Over the past century, pathologists have observed distinctively large mononucleated or multinucleated giant cancer cells, termed polyploid giant cancer cells (PGCCs). These cells, characterized by multiple copies of the genome, significantly contribute to nuclear atypia—a crucial diagnostic criterion in cancer grading and malignancy assessment. Detected in approximately 37-50% of human cancers, polyploid genomes represent one of the most prevalent genetic alterations in cancer. PGCCs, prevalent in high-grade malignant tumors across various organs—such as the breast, ovary, uterus, pancreas, colon, lung, brain, and in leukemia, lymphoma, and
Source: mdanderson.cloud-cme.comCategories: General Medicine News, Onc News and JournalsTweet-
Join us Feb. 16-17 for the inaugural International Conference on Polyploid Giant Cancer Cells. Submit an abstract to present research and be part of the dialogue shaping the future of cancer care. Learn more: https://t.co/tqoFEZq0gz #EndCancer
-
-
Mashup Score: 4Cancer Neuroscience Symposium 2024 - MDA - Continuing Education (CE) - 12 month(s) ago
MDA, Cancer Neuroscience Symposium 2024, 2/28/2024 1:00:00 PM – 3/1/2024 4:00:00 PM, MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes. This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will b
Source: mdanderson.cloud-cme.comCategories: General Medicine News, General Journals & SocietTweet-
Announcing the 2024 Cancer Neuroscience Symposium, February 28 – March 1! Join Wiley and MD Anderson Cancer Center for important conversations about the latest advances in our shared journey to #EndCancer. Learn more and register now: https://t.co/Ynq2QPmgtb @MDAndersonNews https://t.co/VfxlnithTl
-
-
Mashup Score: 1Cancer Neuroscience Symposium - MDA - Continuing Education (CE) - 12 month(s) ago
MDA, Cancer Neuroscience Symposium, 2/28/2024 1:00:00 PM – 3/1/2024 4:00:00 PM, MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes. This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring
Source: mdanderson.cloud-cme.comCategories: General Medicine News, Onc News and JournalsTweet-
MD Anderson Cancer Center and Wiley are proud to bring you a symposium that transcends boundaries. Whether you're on-site or joining virtually, seize the chance to absorb groundbreaking discussions. Secure your spot NOW! @MDAndersonNews #EndCancer https://t.co/vlORI5M3o4 https://t.co/4cFeWYvmZF
-
-
Mashup Score: 2Cancer Neuroscience Symposium - MDA - Continuing Education (CE) - 12 month(s) ago
MDA, Cancer Neuroscience Symposium, 2/28/2024 1:00:00 PM – 3/1/2024 4:00:00 PM, MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes. This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring
Source: mdanderson.cloud-cme.comCategories: General Medicine News, General HCPsTweet-
MD Anderson Cancer Center and Wiley are proud to bring you a symposium that transcends boundaries. Whether you're on-site or joining virtually, seize the chance to absorb groundbreaking discussions. Secure your spot NOW! @MDAndersonNews #EndCancer https://t.co/uZdWKrJK4b https://t.co/YSkqlwFbI8
-
-
Mashup Score: 41st International Conference on Polyploid Giant Cancer Cells: Biology and Clinical Applications - MDA - Continuing Education (CE) - 1 year(s) ago
MDA, 1st International Conference on Polyploid Giant Cancer Cells: Biology and Clinical Applications, 2/16/2024 7:00:00 AM – 2/17/2024 5:00:00 PM, We cordially invite Scientists, Oncologists, Post-Doctoral Fellows, and Graduate Students engaged in cancer research to join us for the inaugural International Conference on Polyploid Giant Cancer Cells. Over the past century, pathologists have observed distinctively large mononucleated or multinucleated giant cancer cells, termed polyploid giant cancer cells (PGCCs). These cells, characterized by multiple copies of the genome, significantly contribute to nuclear atypia—a crucial diagnostic criterion in cancer grading and malignancy assessment. Detected in approximately 37-50% of human cancers, polyploid genomes represent one of the most prevalent genetic alterations in cancer. PGCCs, prevalent in high-grade malignant tumors across various organs—such as the breast, ovary, uterus, pancreas, colon, lung, brain, and in leukemia, lymphoma, and
Source: mdanderson.cloud-cme.comCategories: General Medicine News, Onc News and JournalsTweet-
Join us Feb. 16-17 for the inaugural International Conference on Polyploid Giant Cancer Cells. Submit an abstract to present research and be part of the dialogue shaping the future of cancer care. Learn more: https://t.co/tqoFEZq0gz #EndCancer
-
-
Mashup Score: 1Cancer Neuroscience Symposium - MDA - Continuing Education (CE) - 1 year(s) ago
MDA, Cancer Neuroscience Symposium, 2/28/2024 1:00:00 PM – 3/1/2024 4:00:00 PM, MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes. This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring
Source: mdanderson.cloud-cme.comCategories: General Medicine News, General HCPsTweet-
🗓️ Save the date! Join us for a symposium that promises cutting-edge discussions and contributions from the best in the field. Secure your spot—whether in person or virtually—by registering TODAY! @MDAndersonNews #EndCancer https://t.co/t2fXoVsWNm https://t.co/XissruFGvF
-
Save the date for MD Anderson’s 7th Annual Hereditary Cancer Symposium for Health Care Providers on April 5-6. Register at https://t.co/USZ9f68E6w #EndCancer https://t.co/dm9PGCBaae